120 related articles for article (PubMed ID: 11528587)
1. Late and atypical cytomegalovirus disease in solid-organ transplant recipients.
Slifkin M; Tempesti P; Poutsiaka DD; Snydman DR
Clin Infect Dis; 2001 Oct; 33(7):E62-8. PubMed ID: 11528587
[TBL] [Abstract][Full Text] [Related]
2. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV
J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790
[TBL] [Abstract][Full Text] [Related]
3. Late cytomegalovirus disease with atypical presentation in renal transplant patients: case reports.
Boobes Y; Al Hakim M; Dastoor H; Bernieh B; Abdulkhalik S
Transplant Proc; 2004; 36(6):1841-3. PubMed ID: 15350493
[TBL] [Abstract][Full Text] [Related]
4. Delayed onset CMV disease in solid organ transplant recipients.
Husain S; Pietrangeli CE; Zeevi A
Transpl Immunol; 2009 May; 21(1):1-9. PubMed ID: 19162183
[TBL] [Abstract][Full Text] [Related]
5. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.
Murray BM; Subramaniam S
Transpl Infect Dis; 2004 Mar; 6(1):3-9. PubMed ID: 15225220
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and outcomes of cytomegalovirus retinitis after transplantation.
Eid AJ; Bakri SJ; Kijpittayarit S; Razonable RR
Transpl Infect Dis; 2008 Feb; 10(1):13-8. PubMed ID: 17511815
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
Cummins NW; Deziel PJ; Abraham RS; Razonable RR
Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
[TBL] [Abstract][Full Text] [Related]
8. Late cytomegalovirus disease following liver transplantation.
Shibolet O; Ilan Y; Kalish Y; Safadi R; Ashur Y; Eid A; Shouval D; Wolf D
Transpl Int; 2003 Dec; 16(12):861-5. PubMed ID: 12904846
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
Fisher RA
Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345
[TBL] [Abstract][Full Text] [Related]
10. The role of early colonoscopy in CMV colitis of transplant recipients.
Korkmaz M; Kunefeci G; Selcuk H; Unal H; Gur G; Yilmaz U; Arslan H; Demirhan B; Boyacioglu S; Haberal M
Transplant Proc; 2005 Sep; 37(7):3059-60. PubMed ID: 16213304
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies.
Singh N
J Clin Virol; 2006 Apr; 35(4):474-7. PubMed ID: 16406798
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and clinical outcomes of cytomegalovirus disease occurring more than one year post solid organ transplantation.
Blyth D; Lee I; Sims KD; Gasink LB; Barton TD; Van Deerlin VM; Pfeiffenberger P; Blumberg EA
Transpl Infect Dis; 2012 Apr; 14(2):149-55. PubMed ID: 22260410
[TBL] [Abstract][Full Text] [Related]
13. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system.
Steininger C
Clin Microbiol Infect; 2007 Oct; 13(10):953-63. PubMed ID: 17803749
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation.
Ghisetti V; Barbui A; Franchello A; Varetto S; Pittaluga F; Bobbio M; Salizzoni M; Marchiaro G
J Med Virol; 2004 Jun; 73(2):223-9. PubMed ID: 15122796
[TBL] [Abstract][Full Text] [Related]
17. Signs and symptoms of cytomegalovirus disease in kidney transplant recipients.
Pour-Reza-Gholi F; Labibi A; Farrokhi F; Nafar M; Firouzan A; Einollahi B
Transplant Proc; 2005 Sep; 37(7):3056-8. PubMed ID: 16213303
[TBL] [Abstract][Full Text] [Related]
18. TH1/TH2 cytokine release pattern during in vivo cytomegalovirus disease in solid organ transplantation.
Cervera C; Filella X; Linares L; Pineda M; Esteva C; Antón A; Marcos MA; Cofán F; Navasa M; Pérez-Villa F; Pumarola T; Moreno A
Transplant Proc; 2007 Sep; 39(7):2233-5. PubMed ID: 17889148
[TBL] [Abstract][Full Text] [Related]
19. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
Legendre C; Pascual M
Clin Infect Dis; 2008 Mar; 46(5):732-40. PubMed ID: 18220478
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
